Marshall Wace North America’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,643
| Closed | -$301K | – | 1860 |
|
|
2021
Q2 | $301K | Buy |
+1,643
| New | +$301K | ﹤0.01% | 1223 |
|
|
2021
Q1 | – | Sell |
-642,648
| Closed | -$100M | – | 1900 |
|
|
2020
Q4 | $100M | Buy |
642,648
+637,683
| +12,844% | +$99.6M | 0.45% | 42 |
|
|
2020
Q3 | $568K | Sell |
4,965
-152,766
| -97% | -$17.5M | ﹤0.01% | 941 |
|
|
2020
Q2 | $17.7M | Buy |
157,731
+145,334
| +1,172% | +$16.3M | 0.12% | 194 |
|
|
2020
Q1 | $1.11M | Sell |
12,397
-190,805
| -94% | -$17.1M | 0.01% | 600 |
|
|
2019
Q4 | $22M | Sell |
203,202
-147,587
| -42% | -$16M | 0.11% | 191 |
|
|
2019
Q3 | $34.4M | Sell |
350,789
-16,565
| -5% | -$1.62M | 0.2% | 121 |
|
|
2019
Q2 | $48.1M | Sell |
367,354
-248,883
| -40% | -$32.6M | 0.3% | 91 |
|
|
2019
Q1 | $83.3M | Buy |
616,237
+193,470
| +46% | +$26.2M | 0.59% | 47 |
|
|
2018
Q4 | $41.2M | Buy |
422,767
+23,475
| +6% | +$2.29M | 0.4% | 70 |
|
|
2018
Q3 | $55.5M | Sell |
399,292
-605,877
| -60% | -$84.2M | 0.38% | 66 |
|
|
2018
Q2 | $125M | Sell |
1,005,169
-79,722
| -7% | -$9.9M | 0.7% | 24 |
|
|
2018
Q1 | $121M | Buy |
1,084,891
+982,419
| +959% | +$110M | 0.61% | 31 |
|
|
2017
Q4 | $12.3M | Sell |
102,472
-2,311
| -2% | -$276K | 0.07% | 331 |
|
|
2017
Q3 | $14.7M | Sell |
104,783
-7,515
| -7% | -$1.05M | 0.09% | 279 |
|
|
2017
Q2 | $13.7M | Sell |
112,298
-426,704
| -79% | -$52.1M | 0.1% | 252 |
|
|
2017
Q1 | $65.2M | Buy |
+539,002
| New | +$65.2M | 0.51% | 41 |
|
|
2013
Q4 | $4.05M | Buy |
+30,427
| New | +$4.05M | 0.09% | 208 |
|